Skip to content
Open access

Comparison of Methods for Incorporating Related Data When Developing Clinical Prediction Models: A Simulation Study

Aug 2026 · Biometrical journal. Biometrische Zeitschrift · Vol 68 · 0 citations · 54 references
Medicine

TL;DR

In which situations the ancillary data affect CPM performance, given potential heterogeneity, this study explores in which situations the ancillary data affect CPM performance, given potential heterogeneity.

Abstract

ABSTRACT Clinical Prediction Models (CPMs) compute an individual's risk of an outcome, given a set of predictors. Guidance states CPMs should be constructed using data sampled from the target population. However, researchers might have access to ancillary data sets from different time points, countries, or healthcare settings, which could support model development. This study explores in which situations the ancillary data affect CPM performance, given potential heterogeneity. We conducted a simulation study to assess the impact of heterogeneity between the target and the ancillary data sets, and their relative sample size, on CPM performance. Target and ancillary populations were generated with varying degrees of heterogeneity. CPMs were developed using target‐only logistic regression, logistic and intercept updating, and importance weighting using propensity scores. These models were evaluated on independent data using calibration, discrimination, and prediction stability. Also, a real‐world case study was used as an illustrative example of application using the SWEDEHEART registry. Incorporating ancillary data generally improve CPM performance. Logistic and Intercept Recalibration often outperformed the target‐only regression approach. However, Logistic Recalibration showed greater variability and instability in calibration, while Intercept Recalibration performed poorly under predictor–outcome association shift. The importance weighting method demonstrated consistent performance across a wide range of scenarios and appears to be a reliable alternative, particularly in practical settings where the presence and type of data distribution shift is often unknown.

Read PDF

Similar papers

Open access Aug 2026

Adjusting Survival Curves to Incorporate External Evidence: A Simplified Approach without Patient-Level Data

Introduction: Cost-effectiveness modeling often requires the extrapolation of survival data from clinical trials. The choice of extrapolation method is often uncertain and can have a profound effect on the results. We propose an approach that incorporates external evidence (eg, from published studies, registries, or el...

David McConnell, Arthur White, F. Lamrock et al. · 0 citations
Open access Sep 2026

Evaluating discrimination of prediction models for recurrent clinical events

This study provides practical methods and open-source code for evaluating the discrimination of prediction models for recurrent event data and proposes adapted discrimination statistics based on comparing predicted and observed cumulative event counts, addressing limitations of conventional concordance approaches.

T. Spain, Alexandra Hunt, Maria Sudell et al. · 0 citations
Jul 2026

Are Limited Electronic Medical Record Follow-Up Data Sufficiently Useful for Validating the Performance of Survival Prediction Models?

PURPOSE Machine learning models that predict survival time for patients are increasingly used for clinical decision support. Validating model performance in deployment is important but challenging because the only timely source of follow-up/death data is the electronic medical record (EMR), which is known to undercaptu...

Vigneshwari Subramanian, Tyler Raclin, B. Narasimhan et al. · 0 citations
Preprint Sep 2026

Bayesian additive regression trees for evaluating treatment benefit predictors using observational data

A treatment benefit predictor (TBP) is an algorithm that maps a patient's characteristics to their putative benefit from a given treatment, which can be used to inform treatment decisions. However, a TBP must be evaluated in the target population before being adopted for patient care. When only observational data are a...

Yuan Xia, M. Sadatsafavi, J. Mehareen et al. · 0 citations
Review Open access Sep 2026

Clinical Prediction Models in Cardiovascular Disease: Foundations, Clinical Applications and Future Directions.

This review aims to contextualize the bench-to-bedside translational gap, offering an evidence-based roadmap for clinicians, statisticians, and data scientists to safely harness predictive modeling and ensure meaningful improvements in patient outcomes.

Bing-Yi Wang, A. Franciosi, L. O'Neill et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.